ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Concrete100
|
244 |
85K |
1 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
244
|
85K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Concrete100
|
244 |
85K |
0 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
244
|
85K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Concrete100
|
881 |
338K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
881
|
338K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Concrete100
|
881 |
338K |
0 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
881
|
338K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Concrete100
|
881 |
338K |
1 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
881
|
338K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Concrete100
|
881 |
338K |
3 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
881
|
338K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Concrete100
|
881 |
338K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
881
|
338K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Concrete100
|
881 |
338K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
881
|
338K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
$2/s is near
|
|
Concrete100
|
65 |
29K |
0 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
65
|
29K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
$2/s is near
|
|
Concrete100
|
65 |
29K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
65
|
29K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
$2/s is near
|
|
Concrete100
|
65 |
29K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
65
|
29K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
$2/s is near
|
|
Concrete100
|
65 |
29K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
65
|
29K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
$2/s is near
|
|
Concrete100
|
65 |
29K |
8 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
65
|
29K
|
8
|
|